Heart Valve Devices Market Size

Heart Valve Devices Market size was valued at around USD 6.1 billion in 2023 and is anticipated to register a CAGR of over 8.6% between 2024 and 2032. This robust market growth can be attributed to factors such as the increasing prevalence of cardiovascular diseases, government initiatives and funding support, and rising preference for minimally invasive procedures.

Heart valve devices refer to medical implants or prosthetic devices designed to replace, repair, or support the proper functioning of heart valves. These devices are utilized in the treatment of various heart conditions, including valvular diseases or malfunctions that impede the normal flow of blood within the heart.

Cardiovascular diseases such as valvular disorders have become a leading cause of morbidity and mortality worldwide.  For instance, according to an article published by the World Heart Federation, in 2023, deaths from cardiovascular disease (CVD) jumped globally from 12.1 million in 1990 to 20.5 million in 2021. The increasing prevalence of these diseases contributes substantially to the growth of the market.

As the global population ages, there is a parallel increase in the prevalence of coronary heart disease (CHD). According to the Centers for Disease Prevention and Control, in 2019, 7.1% of adults aged 45 to 64 years reported having CHD compared with 17% of adults aged 65 years and older. These statistics indicate a notable increase in the demand for heart valve devices for individuals suffering from various cardiovascular disorders.